Skip to main content
. 2024 Aug 26;16(17):2970. doi: 10.3390/cancers16172970

Table 1.

Antibodies used in this study.

Antibody Source and Cat. No. Dilution
IHC WB IF
Rabbit polyclonal anti-VDAC1 ab15895, Abcam, Cambridge, UK 1:400 1:15,000 1:500
Rabbit polyclonal anti-KI-67 ab15580, Abcam, Cambridge, UK 1:500
Rabbit polyclonal anti-Glut 1 ab652, Abcam, Cambridge, UK, 1:500
Rabbit polyclonal anti-ATP5A ab151229, Abcam, Cambridge, UK 1:500
Mouse monoclonal anti-SOX2 ab171380, Abcam, Cambridge, UK 1:200
Rabbit polyclonal anti-CD44 ab157107, Abcam, Cambridge, UK 1:800 1:1000
Rabbit monoclonal anti-HK-I ab150423, Abcam, Cambridge, UK 1:100
Rabbit polyclonal anti-CD133 ab19898, Abcam, Cambridge, UK 1:200
Rabbit monoclonal anti-synaptophysin ab32127, Abcam, Cambridge UK 1:500
Rabbit polyclonal anti-citrate synthetase ab96600, Abcam, Cambridge, UK 1:500 1:500
Rabbit monoclonal anti-ALDH1 ab52492, Abcam, Cambridge, UK 1:50
Mouse monoclonal anti-β-actin MAB1501, Millipore, Billerica, MA 1:40,000
Donkey anti-Mouse (Alexa Fluor 488) ab150109, Abcam, Cambridge, UK 1:750
Goat anti-Rabbit (Alexa Fluor 555) ab150086, Abcam, Cambridge, UK 1:850
Goat anti-Rabbit HRP W4018, Promega, Wisconsin 1:1000 1:15,000
Donkey anti-Mouse HRP ab98799, Abcam, Cambridge, UK 1:1000